Promising anti-IGF-1R antibody for thyroid eye disease has extended half-life and can be self-administered – BioWorld Online

Subscribe to BioWorld™ news services
Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.
Copyright ©2024. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing
Cookie Settings

source

About The Author

admin

See author's posts